Krishnan, A., Schneider, C. V., Mukherjee, D., Woreta, T. A., & Alqahtani, S. A. (2025). Adverse Liver and Renal Outcomes After Initiating SGLT‐2i and GLP‐1RA Therapy Among Patients With Diabetes and MASLD. Wiley. https://doi.org/10.1111/1753-0407.70069
Chicago Style (17th ed.) CitationKrishnan, Arunkumar, Carolin V. Schneider, Diptasree Mukherjee, Tinsay A. Woreta, and Saleh A. Alqahtani. Adverse Liver and Renal Outcomes After Initiating SGLT‐2i and GLP‐1RA Therapy Among Patients With Diabetes and MASLD. Wiley, 2025. https://doi.org/10.1111/1753-0407.70069.
MLA (9th ed.) CitationKrishnan, Arunkumar, et al. Adverse Liver and Renal Outcomes After Initiating SGLT‐2i and GLP‐1RA Therapy Among Patients With Diabetes and MASLD. Wiley, 2025. https://doi.org/10.1111/1753-0407.70069.